Jonathan George, MD, MPH

Head and neck surgeon

Dr. Jonathan R. George is a surgeon specializing in head and neck cancer care. His primary areas of focus are thyroid cancer and head and neck melanoma surgery. More broadly, he offers surgery for thyroid/parathyroid diseases as well as cutaneous and aerodigestive tract malignancies of the head and neck, such as throat/larynx cancers and oral cavity cancers.

For endocrine patients, George offers comprehensive management of thyroid nodules, multinodular goiters, recurrent and locally advanced thyroid cancers and parathyroid diseases. For melanoma patients, his care includes melanoma excision, sentinel lymph node biopsy, neck dissection and expedited aesthetic closure by UCSF facial plastic surgeons.

George obtained his M.D. degree from Duke University School of Medicine and his B.A. from Amherst College, both with honors. He received an M.P.H. in head and neck cancer epidemiology at the University of North Carolina Gillings School of Global Public Health. He then completed a two-year clinical and translational research fellowship in head and neck cancer at the University of North Carolina at Chapel Hill. He completed residency training at UCSF Medical Center in otolaryngology-head and neck surgery, followed by a fellowship in advanced head and neck surgical oncology at M.D. Anderson Cancer Center in Houston, Tex. George is a member of the American Head and Neck Society and the American Thyroid Association, and is certified by the American Board of Otolaryngology.He is a surgeon member of UCSF's multidisciplinary Head and Neck Oncology and Cutaneous Oncology programs. His academic research focuses on prospective clinical trials to advance targeted treatment of thyroid and head and neck cancers. He is also a member of UCSF's National Cancer Institute-designated UCSF Helen Diller Family Comprehensive Cancer Center.

George is committed to providing comprehensive, compassionate care with a focus on disease cure and excellent outcomes while maintaining a directly accessible relationship with each patient. He provides expedited consultations for all patients. To request an evaluation, please email him directly at jonathan.george@ucsf.edu or call his clinic at (415) 514-4890 or (415) 885-7528, fax (415) 885-7711.

Clinics

Head and Neck Surgery Cancer Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 885–7528
Fax: (415) 885–7711

Hours: Monday to Friday
8 a.m. – 5 p.m.

Thyroid and Parathyroid Surgery
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 885-7528
Fax: (415) 885-7711

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Conditions & Treatments

Board Certification

Otolaryngology, American Board of Otolaryngology

Academic Title

Assistant Professor

More about Jonathan George

Education

Duke University School of Medicine 2008

Residencies

UCSF Medical Center, Otolaryngology – Head and Neck Surgery 2013

Fellowships

M.D. Anderson Cancer Center, Advanced Head and Neck Surgical Oncology Fellowship 2014

Selected Research and Publications

  1. Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-Sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy. Head Neck. 2018 Mar 10.
  2. Tamplen ML, Tamplen J, Shuman E, Heaton CM, George JR, Wang SJ, Ryan WR. Comparison of Output Volume Thresholds for Drain Removal After Selective Lateral Neck Dissection: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2017 Dec 01; 143(12):1195-1199.
  3. Heaton CM, Yu K, Calkins S, George JR, Ryan WR, Wang SJ. Clinicopathologic characteristics and outcomes of recurrent oropharyngeal squamous cell carcinoma. Am J Otolaryngol. 2016 Nov - Dec; 37(6):513-516.
  4. Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa AA, George JR, Yom SS. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy. J Med Imaging Radiat Oncol. 2016 Aug; 60(4):560-7.
  5. George JR, Henderson YC, Williams MD, Roberts DB, Hei H, Lai SY, Clayman GL. Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC. J Clin Endocrinol Metab. 2015 Dec; 100(12):E1550-9.
  6. George JR, Yom SS, Wang SJ. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis. Laryngoscope. 2014 Jul; 124(7):1603-8.
  7. George JR, Yom SS, Wang SJ. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1118-26.
  8. Clark AJ, Jahangiri A, Garcia RM, George JR, Sughrue ME, McDermott MW, El-Sayed IH, Aghi MK. Endoscopic surgery for tuberculum sellae meningiomas: a systematic review and meta-analysis. Neurosurg Rev. 2013 Jul; 36(3):349-59.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.